Journal of Bone and Mineral Metabolism

, Volume 31, Issue 2, pp 169–176 | Cite as

A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis

  • Anna Straburzyńska-Lupa
  • Alicja Nowak
  • Wojciech Romanowski
  • Paweł Korman
  • Łucja Pilaczyńska-Szcześniak
Original Article
First Online:
Received:
Accepted:

Abstract

In this study, the levels of bone turnover markers (BTMs) and bone mineral density (BMD) were studied in relation to body mass and several inflammatory markers, in postmenopausal patients with rheumatoid arthritis (RA). Fifty-nine postmenopausal women with active RA (lean, overweight, obese) were studied. The femoral BMD and serum levels of BTMs: osteocalcin (OC) and collagen type I cross-linked C-telopeptide fragments (CTX), and osteopontin (OPN), resistin, high sensitivity C-reactive protein, interleukin-6, tumor necrosis factor (TNF)-α in these patients were measured. It has been noticed that obese women had significantly higher total femoral BMD and total T-score compared to the lean subjects (p ≤ 0.01). The significant associations of BMD measures and CTX levels with body mass parameters (p ≤ 0.01 and p < 0.05, respectively) were found. Values of neck BMD adjusted for BMI were inversely associated with concentrations of TNF-α (p < 0.05). Osteocalcin levels inversely correlated with resistin (p ≤ 0.01) and CTX levels positively correlated with OPN (p ≤ 0.01). There were found no associations between BTMs and BMD with other inflammatory indices. Inverse correlations between OPN levels and body mass (p < 0.05), waist circumference (p < 0.05), and duration of postmenopausal period (p ≤ 0.01) were observed. Findings of the present study suggest that body mass and inflammatory markers, most of all OPN, resistin and TNF-α, play an important role in bone metabolism in postmenopausal women with active RA.

Keywords

Bone Osteopontin Resistin Body mass index Rheumatoid arthritis 
This is a preview of subscription content, log in to check access.

Notes

Conflict of interest

None.

References

  1. 1.
    Kröger H, Honkanen R, Saarikoski S, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis—a population based study. Ann Rheum Dis 53:18–23PubMedCrossRefGoogle Scholar
  2. 2.
    Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K, Solomon DH (2010) Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12:R154PubMedCrossRefGoogle Scholar
  3. 3.
    Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522–530PubMedCrossRefGoogle Scholar
  4. 4.
    Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV, Task Force of the FRAX Initiative (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:2395–2411PubMedCrossRefGoogle Scholar
  5. 5.
    Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA, For the IOF-IFCC Bone Marker Standards Working Group (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420PubMedCrossRefGoogle Scholar
  6. 6.
    Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV (1993) The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 36:1510–1516PubMedCrossRefGoogle Scholar
  7. 7.
    Book C, Karlsson M, Akesson K, Jacobsson L (2008) Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol 37:248–254PubMedCrossRefGoogle Scholar
  8. 8.
    Momohara S, Okamoto H, Yago T, Furuya T, Nanke Y, Kotake S, Soejima M, Mizumura T, Ikari K, Tomatsu T (2005) The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis. Mod Rheumatol 15:410–414PubMedCrossRefGoogle Scholar
  9. 9.
    Miranda-Carús ME, Benito-Miguel M, Balsa A, Cobo-Ibáñez T, Pérez de Ayala C, Pascual-Salcedo D, Martín-Mola E (2006) Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis Rheum 54:1151–1164PubMedCrossRefGoogle Scholar
  10. 10.
    Le Goff B, Blanchard F, Berthelot JM, Heymann D, Maugars Y (2010) Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine 77:201–205PubMedCrossRefGoogle Scholar
  11. 11.
    Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ (2002) TNFα potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143:1108–1118PubMedCrossRefGoogle Scholar
  12. 12.
    Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005) Resistin, an adipokine with potent proinflammatory properties. J Immunol 174(9):5789–5795Google Scholar
  13. 13.
    Almehed K, d’Elia HF, Bokarewa M, Carlsten H (2008) Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther 10:R15. doi: 10.1186/ar2366
  14. 14.
    Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, Eguchi K (2006) The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol 24:698–701PubMedGoogle Scholar
  15. 15.
    Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21:1401–1409PubMedCrossRefGoogle Scholar
  16. 16.
    Yoshitake H, Rittling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156–8160PubMedCrossRefGoogle Scholar
  17. 17.
    Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067PubMedGoogle Scholar
  18. 18.
    Kojima H, Uede T, Uemura T (2004) In vitro and in vivo effects of the overexpression of osteopontin on osteoblast differentiation using a recombinant adenoviral vector. J Biochem 136:377–386PubMedCrossRefGoogle Scholar
  19. 19.
    Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302–2309PubMedCrossRefGoogle Scholar
  20. 20.
    Finkelstein JS, Brockwell SE, Mehta V, Greendale GA, Sowers MR, Ettinger B, Lo JC, Johnston JM, Cauley JA, Danielson ME, Neer RM (2008) Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab 93:861–868PubMedCrossRefGoogle Scholar
  21. 21.
    Baker JF, George M, Baker DG, Toedter G, Von Feldt JM, Leonard MB (2011) Associations between body mass, radiographic joint damage, adipokines and risk factors for bone loss in rheumatoid arthritis. Rheumatology 50(11):2100–2107PubMedCrossRefGoogle Scholar
  22. 22.
    Gómez-Ambrosi J, Catalán V, Ramírez B, Rodríguez A, Colina I, Silva C, Rotellar F, Mugueta C, Gil MJ, Cienfuegos JA, Salvador J, Frühbeck G (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92:3719–3727PubMedCrossRefGoogle Scholar
  23. 23.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  24. 24.
    Garnero P, Delmas PD (2004) Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 4:50–63PubMedGoogle Scholar
  25. 25.
    Kröger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S (1994) Bone mineral density and risk factors for osteoporosis- a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55:1–7PubMedCrossRefGoogle Scholar
  26. 26.
    Pye SR, Marshall T, Gaffney K, Silman AJ, Symmons DP, O’Neill TW (2010) Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMDa) in women with longstanding inflammatory polyarthritis: a primary care based inception cohort. BMC Musculoskelet Disord 11:106PubMedCrossRefGoogle Scholar
  27. 27.
    Frost HM (1992) Perspectives: bone’s mechanical usage windows. Bone Miner 19:257–271PubMedCrossRefGoogle Scholar
  28. 28.
    Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J (1998) Concentration of sex steroids in adipose tissue after menopause. Steroids 63:319–321PubMedCrossRefGoogle Scholar
  29. 29.
    Barrett-Connor E, Kritz-Silverstein D (1996) Does hyperinsulinemia preserve bone? Diabetes Care 19:1388–1392PubMedCrossRefGoogle Scholar
  30. 30.
    Ishii T, Ohshima S, Ishida T, Mima T, Tabunoki Y, Kobayashi H, Maeda M, Uede T, Liaw L, Kinoshita N, Kawase I, Saeki Y (2004) Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochem Biophys Res Commun 316:809–815PubMedCrossRefGoogle Scholar
  31. 31.
    Marotte H, Miossec P (2008) Prevention of bone mineral density loss in patients with rheumatoid arthritis treated with anti-TNFα therapy. Biologics Targets Ther 2:663–669Google Scholar
  32. 32.
    Barnabe C, Hanley DA (2009) Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy. Semin Arthritis Rheum 39:116–122PubMedCrossRefGoogle Scholar
  33. 33.
    Bonnet J, Zerath E, Picaud N, Lesur C, Mattio A, Tordjman C, Hott M, Marie PJ (1993) Bone morphometric changes in adjuvant induced polyarthritis osteopenia in rats: evidence for an early bone formation defect. J Bone Miner Res 8:659–668PubMedCrossRefGoogle Scholar
  34. 34.
    Vergély N, Lafage-Proust MH, Caillot-Augusseau A, Millot L, Lang F, Estour B (2002) Hypercorticism blunts circadian variations of osteocalcin regardless of nutritional status. Bone 30:428–435PubMedCrossRefGoogle Scholar
  35. 35.
    Haugen F, Jørgensen A, Drevon CA, Trayhurn P (2001) Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS 507(1):105–108CrossRefGoogle Scholar
  36. 36.
    Thommesen L, Stunes AK, Monjo M, Grøsvik K, Tamburstuen MV, Kjøbli E, Lyngstadaas SP, Reseland JE, Syversen U (2006) Expression and regulation of resistin in osteoblasts and osteoclasts indicate role in bone metabolism. J Cell Biochem 99:824–834PubMedCrossRefGoogle Scholar
  37. 37.
    Forsblad d’Elia H, Pullerits R, Carlsten H, Bokarewa M (2008) Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology 47:1082–1087PubMedCrossRefGoogle Scholar
  38. 38.
    Seriolo B, Ferretti V, Sulli A, Caratto E, Fasciolo D, Cutolo M (2002) Serum osteocalcin levels in premenopausal rheumatoid arthritis patients. Ann NY Acad Sci 966:502–507PubMedCrossRefGoogle Scholar
  39. 39.
    Bazzichi L, Ghiadoni L, Rossi A, Bernardini M, Lanza M, De Feo F, Giacomelli C, Mencaroni I, Raimo K, Rossi M, Mazzone AM, Taddei S, Bombardieri S (2009) Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis. Mol Med 15:402–406PubMedCrossRefGoogle Scholar
  40. 40.
    Sharif SA, Du X, Myles T, Song JJ, Price E, Lee DM, Goodman SB, Nagashima M, Morser J, Robinson WH, Leung LL (2009) Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis Rheum 60:2902–2912PubMedCrossRefGoogle Scholar
  41. 41.
    Trayhurn P, Wood IS (2004) Adipokines: inflammation and pleiotropic role of white adipose tissue. Br J Nutr 92:347–355PubMedCrossRefGoogle Scholar
  42. 42.
    Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978PubMedCrossRefGoogle Scholar
  43. 43.
    Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes Res 11:997–1001PubMedCrossRefGoogle Scholar
  44. 44.
    Straburzyńska-Lupa A, Nowak A, Pilaczyńska-Szcześniak Ł, Straburzyńska-Migaj E, Romanowski W, Karolkiewicz J, Sliwicka E (2010) Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol 28:19–24PubMedGoogle Scholar
  45. 45.
    Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Panoulas VF, Douglas KM, Jamurtas AZ, Koutedakis Y, Kitas GD (2010) What predicts obesity in patients with rheumatoid arthritis? An investigation of the interactions between lifestyle and inflammation. Int J Obes (Lond) 34:295–301CrossRefGoogle Scholar
  46. 46.
    van der Helm-van Mil AH, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW (2008) A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis 67:769–774PubMedCrossRefGoogle Scholar
  47. 47.
    Yoneda T, Ishimaru N, Arakaki R, Kobayashi M, Izawa T, Moriyama K, Hayashi Y (2004) Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappaB ligand-mediated osteoclastogenesis. Endocrinology 145:2384–2391PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society for Bone and Mineral Research and Springer Japan 2012

Authors and Affiliations

  • Anna Straburzyńska-Lupa
    • 2
    • 3
  • Alicja Nowak
    • 1
  • Wojciech Romanowski
    • 3
  • Paweł Korman
    • 2
  • Łucja Pilaczyńska-Szcześniak
    • 1
  1. 1.Department of HygieneUniversity School of Physical EducationPoznanPoland
  2. 2.Department of PhysiotherapyUniversity School of Physical EducationPoznanPoland
  3. 3.Rheumatological Centre ŚremŚremPoland

Personalised recommendations